{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:14:37Z","timestamp":1791299677742,"version":"4.1.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.molimm.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:36:19Z","timestamp":1411086979000},"page":"193-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection"],"prefix":"10.1016","volume":"63","author":[{"given":"Xingmin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.molimm.2014.09.005_bib0580","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1128\/AAC.48.10.3975-3979.2004","article-title":"Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters","volume":"48","author":"Anton","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"16","key":"10.1016\/j.molimm.2014.09.005_bib0585","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2165\/00003495-200565160-00002","article-title":"Biologic therapy for inflammatory bowel disease","volume":"65","author":"Ardizzone","year":"2005","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0590","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/14728214.2012.744820","article-title":"Immunosuppressive and biologic therapy for ulcerative colitis","volume":"17","author":"Ardizzone","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1043-6618(02)00264-5","article-title":"Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety","volume":"47","author":"Arnott","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.molimm.2014.09.005_bib0600","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.micinf.2006.07.009","article-title":"Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells","volume":"8","author":"Ausiello","year":"2006","journal-title":"Microbes Infect."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0605","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3201\/eid\/1706.101483","article-title":"Binary toxin and death after Clostridium difficile infection","volume":"17","author":"Bacci","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0610","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/mpat.1994.1030","article-title":"Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity","volume":"16","author":"Barroso","year":"1994","journal-title":"Microb. Pathog."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0615","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","article-title":"Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea","volume":"38","author":"Barbut","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib0620","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0016-5085(78)90457-2","article-title":"Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis","volume":"75","author":"Bartlett","year":"1978","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.molimm.2014.09.005_bib0625","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","article-title":"Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia","volume":"298","author":"Bartlett","year":"1978","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib0630","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4161\/gmic.19526","article-title":"Models for the study of Clostridium difficile infection","volume":"3","author":"Best","year":"2012","journal-title":"Gut Microbes"},{"issue":"Pt 8","key":"10.1016\/j.molimm.2014.09.005_bib0635","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1099\/jmm.0.029694-0","article-title":"Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains","volume":"60","author":"Bianco","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2014.09.005_bib0640","doi-asserted-by":"crossref","first-page":"462740","DOI":"10.1155\/2014\/462740","article-title":"Role of microbiota and innate immunity in recurrent Clostridium difficile infection","volume":"2014","author":"Bibbo","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"Pt 2","key":"10.1016\/j.molimm.2014.09.005_bib0645","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/0264-6021:3480241","article-title":"Rho GTPases and their effector proteins","volume":"348","author":"Bishop","year":"2000","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib0650","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1086\/518874","article-title":"The challenges posed by reemerging Clostridium difficile infection","volume":"45","author":"Blossom","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib0655","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1093\/clinids\/12.Supplement_2.S185","article-title":"Virulence factors of Clostridium difficile","volume":"12","author":"Borriello","year":"1990","journal-title":"Rev. Infect. Dis."},{"issue":"C","key":"10.1016\/j.molimm.2014.09.005_bib0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/41.suppl_3.13","article-title":"Pathogenesis of Clostridium difficile infection","volume":"41","author":"Borriello","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib0665","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ajg.2012.450","article-title":"American journal of gastroenterology lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection","volume":"108","author":"Brandt","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0670","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/gast.1997.v112.pm9178681","article-title":"Early functional effects of Clostridium difficile toxin A on human colonocytes","volume":"112","author":"Branka","year":"1997","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib0675","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tim.2012.04.001","article-title":"Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance","volume":"20","author":"Britton","year":"2012","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib0680","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.05496-11","article-title":"Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis","volume":"80","author":"Buffie","year":"2012","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib0685","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1365-2958.2001.02461.x","article-title":"Molecular characterization of the surface layer proteins from Clostridium difficile","volume":"40","author":"Calabi","year":"2001","journal-title":"Mol. Microbiol."},{"issue":"10","key":"10.1016\/j.molimm.2014.09.005_bib0690","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1128\/IAI.70.10.5770-5778.2002","article-title":"Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues","volume":"70","author":"Calabi","year":"2002","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0695","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1128\/IAI.66.6.2755-2761.1998","article-title":"Effects of toxin A from Clostridium difficile on mast cell activation and survival","volume":"66","author":"Calderon","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.09.005_bib0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev-micro-090110-102824","article-title":"Biology of Clostridium difficile: implications for epidemiology and diagnosis","volume":"65","author":"Carroll","year":"2011","journal-title":"Annu. Rev. Microbiol."},{"issue":"20","key":"10.1016\/j.molimm.2014.09.005_bib0700","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JB.00731-07","article-title":"Binary toxin production in Clostridium difficile is regulated by CdtR: a LytTR family response regulator","volume":"189","author":"Carter","year":"2007","journal-title":"J. Bacteriol."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0705","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0016-5085(94)90112-0","article-title":"Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum","volume":"107","author":"Castagliuolo","year":"1994","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.molimm.2014.09.005_bib0710","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.4049\/jimmunol.160.12.6039","article-title":"Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells","volume":"160","author":"Castagliuolo","year":"1998","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.molimm.2014.09.005_bib0715","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.94.9.4788","article-title":"Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats","volume":"94","author":"Castagliuolo","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0720","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","article-title":"A mouse model of Clostridium difficile-associated disease","volume":"135","author":"Chen","year":"2008","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1016\/j.molimm.2014.09.005_bib0725","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamainternmed.2013.7056","article-title":"Epidemiology of community-associated Clostridium difficile infection: 2009 through 2011","volume":"173","author":"Chitnis","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0730","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/mpat.2000.0356","article-title":"Characterization of surface layer proteins from different Clostridium difficile clinical isolates","volume":"28","author":"Cerquetti","year":"2000","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0735","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/BJ20110106","article-title":"Super toxins from a super bug: structure and function of Clostridium difficile toxins","volume":"436","author":"Davies","year":"2011","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib0740","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0924-8579(09)70012-3","article-title":"New trends in Clostridium difficile virulence and pathogenesis","volume":"33","author":"Deneve","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Pt 7","key":"10.1016\/j.molimm.2014.09.005_bib0745","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1099\/mic.0.066712-0","article-title":"A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile","volume":"159","author":"Donald","year":"2013","journal-title":"Microbiology"},{"issue":"12","key":"10.1016\/j.molimm.2014.09.005_bib0750","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/cid\/cit147","article-title":"Markers of intestinal inflammation: not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection","volume":"56","author":"El Feghaly","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib0755","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1445-5994.2007.01403.x","article-title":"Clostridium difficile-associated diarrhoea","volume":"37","author":"Elliott","year":"2007","journal-title":"Intern. Med. J."},{"issue":"35","key":"10.1016\/j.molimm.2014.09.005_bib0760","doi-asserted-by":"crossref","first-page":"25314","DOI":"10.1074\/jbc.M703062200","article-title":"Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity","volume":"282","author":"Egerer","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib0765","doi-asserted-by":"crossref","first-page":"e1000942","DOI":"10.1371\/journal.ppat.1000942","article-title":"Inositol hexakisphosphate-induced autoprocessing of large bacterial protein toxins","volume":"6","author":"Egerer","year":"2010","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib0770","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.immuni.2013.08.039","article-title":"Anthracyclines induce DNA damage response-mediated protection against severe sepsis","volume":"39","author":"Figueiredo","year":"2013","journal-title":"Immunity"},{"issue":"29","key":"10.1016\/j.molimm.2014.09.005_bib0775","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/j.vaccine.2012.01.056","article-title":"Clostridium difficile: development of a novel candidate vaccine","volume":"30","author":"Foglia","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib0780","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.vaccine.2003.11.030","article-title":"Active and passive immunization against Clostridium difficile diarrhea and colitis","volume":"22","author":"Giannasca","year":"2004","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.molimm.2014.09.005_bib0785","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.vaccine.2009.03.058","article-title":"A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A","volume":"27","author":"Gardiner","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0790","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1365-2958.2011.07549.x","article-title":"Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B","volume":"79","author":"Genisyuerek","year":"2011","journal-title":"Mol. Microbiol."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0795","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.01074-12","volume":"81","author":"Ghose","year":"2013","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib0800","doi-asserted-by":"crossref","first-page":"e8740","DOI":"10.1371\/journal.pone.0008740","article-title":"Metabolism of bile salts in mice influences spore germination in Clostridium difficile","volume":"5","author":"Giel","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib0805","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1053\/j.gastro.2008.03.008","article-title":"Human alpha-defensins inhibit Clostridium difficile toxin B","volume":"134","author":"Giesemann","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.molimm.2014.09.005_bib0810","doi-asserted-by":"crossref","first-page":"e81491","DOI":"10.1371\/journal.pone.0081491","article-title":"The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8\/IL-8 production and intestinal epithelial barrier dysfunction","volume":"8","author":"Hansen","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib0815","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.4049\/jimmunol.1003761","article-title":"Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen","volume":"186","author":"Hasegawa","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0820","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.4049\/jimmunol.1200821","article-title":"Protective role of commensals against Clostridium difficile infection via an IL-1beta-mediated positive-feedback loop","volume":"189","author":"Hasegawa","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0825","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/gast.2002.32386","article-title":"Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation","volume":"122","author":"He","year":"2002","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.molimm.2014.09.005_bib0830","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrm2476","article-title":"Mammalian Rho GTPases: new insights into their functions from in vivo studies","volume":"9","author":"Heasman","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"Pt 1","key":"10.1016\/j.molimm.2014.09.005_bib0835","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1099\/00221287-147-1-87","article-title":"GroEL (Hsp60) of Clostridium difficile is involved in cell adherence","volume":"147","author":"Hennequin","year":"2001","journal-title":"Microbiology"},{"issue":"Pt 10","key":"10.1016\/j.molimm.2014.09.005_bib0840","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1099\/mic.0.26145-0","article-title":"Identification and characterization of a fibronectin-binding protein from Clostridium difficile","volume":"149","author":"Hennequin","year":"2003","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0845","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/AAC.00041-08","article-title":"Tolevamer: an anionic polymer, neutralizes toxins produced by the BI\/027 strains of Clostridium difficile","volume":"52","author":"Hinkson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0850","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1756283X11399115","article-title":"Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection","volume":"4","author":"Hickson","year":"2011","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0855","first-page":"433","article-title":"Defective neutrophil chemotactic responses in patients with recurrent episodes of otitis media and chronic diarrhea","volume":"131","author":"Hill","year":"1977","journal-title":"Am. J. Dis. Child."},{"issue":"9","key":"10.1016\/j.molimm.2014.09.005_bib0860","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/gutjnl-2012-302180","article-title":"The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice","volume":"62","author":"Hing","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.molimm.2014.09.005_bib0865","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/IAI.00933-12","article-title":"Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure","volume":"80","author":"Hirota","year":"2012","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib0875","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/gmic.1.1.11036","article-title":"Infectious diarrhea: cellular and molecular mechanisms","volume":"1","author":"Hodges","year":"2010","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib0880","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1574-6968.12367","article-title":"Small animal models for the study of Clostridium difficile disease pathogenesis","volume":"352","author":"Hutton","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib0015","doi-asserted-by":"crossref","first-page":"e69846","DOI":"10.1371\/journal.pone.0069846","article-title":"Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s)","volume":"8","author":"Jafari","year":"2013","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.molimm.2014.09.005_bib0885","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1128\/JB.00578-07","article-title":"Cwp84: a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins","volume":"189","author":"Janoir","year":"2007","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0890","doi-asserted-by":"crossref","first-page":"15R","DOI":"10.1093\/glycob\/cwm004","article-title":"Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function","volume":"17","author":"Jank","year":"2007","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib0895","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tim.2008.01.011","article-title":"Structure and mode of action of clostridial glucosylating toxins: the ABCD model","volume":"16","author":"Jank","year":"2008","journal-title":"Trends Microbiol."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0900","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1128\/IAI.01196-10","article-title":"Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis","volume":"79","author":"Jarchum","year":"2011","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.molimm.2014.09.005_bib0905","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/IAI.00448-12","article-title":"Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis","volume":"80","author":"Jarchum","year":"2012","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.molimm.2014.09.005_bib0910","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1128\/IAI.05372-11","article-title":"Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90","volume":"79","author":"Kaiser","year":"2011","journal-title":"Infect. Immun."},{"issue":"3\u20134","key":"10.1016\/j.molimm.2014.09.005_bib0915","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2009.02.005","article-title":"Trans-10, cis-12 conjugated linoleic acid modulates phagocytic responses of canine peripheral blood polymorphonuclear neutrophilic leukocytes exposed to Clostridium difficile toxin B","volume":"130","author":"Kang","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0920","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1354\/vp.43-3-225","article-title":"The comparative pathology of Clostridium difficile-associated disease","volume":"43","author":"Keel","year":"2006","journal-title":"Vet. Pathol."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0925","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199401273300406","article-title":"Clostridium difficile colitis","volume":"330","author":"Kelly","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0930","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1172\/JCI117080","article-title":"Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit","volume":"93","author":"Kelly","year":"1994","journal-title":"J Clin Invest"},{"issue":"Pt 8","key":"10.1016\/j.molimm.2014.09.005_bib0935","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1099\/jmm.0.030015-0","article-title":"The host immune response to Clostridium difficile","volume":"60","author":"Kelly","year":"2011","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib0940","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1099\/00222615-24-1-41","article-title":"The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits","volume":"24","author":"Ketley","year":"1987","journal-title":"J. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib0945","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1348-0421.2002.tb02704.x","article-title":"Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A","volume":"46","author":"Kim","year":"2002","journal-title":"Microbiol. Immunol."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib0950","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/13543784.2010.495386","article-title":"Future novel therapeutic agents for Clostridium difficile infection","volume":"19","author":"Koo","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0955","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00210-010-0574-x","article-title":"Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A","volume":"383","author":"Kreimeyer","year":"2011","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"7316","key":"10.1016\/j.molimm.2014.09.005_bib0960","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature09397","article-title":"The role of toxin A and toxin B in Clostridium difficile infection","volume":"467","author":"Kuehne","year":"2010","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib0965","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/AAC.45.8.2340-2347.2001","article-title":"GT160-246: a toxin binding polymer for treatment of Clostridium difficile colitis","volume":"45","author":"Kurtz","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib0970","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","author":"Kyne","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib0975","doi-asserted-by":"crossref","first-page":"e1001061","DOI":"10.1371\/journal.ppat.1001061","article-title":"Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile","volume":"6","author":"Lyras","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2014.09.005_bib0980","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.anaerobe.2013.09.008","article-title":"Murine models to study Clostridium difficile infection and transmission","volume":"24","author":"Lawley","year":"2013","journal-title":"Anaerobe"},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib0985","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.vaccine.2009.10.144","article-title":"Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)","volume":"28","author":"Leav","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.molimm.2014.09.005_bib0990","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00109-007-0237-7","article-title":"Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A","volume":"85","author":"Lee","year":"2007","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib0995","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00109-008-0415-2","article-title":"Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38: IKK, and the NF-kappaB signaling pathway","volume":"87","author":"Lee","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib1000","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/IAI.01341-12","article-title":"Protective efficacy induced by recombinant Clostridium difficile toxin fragments","volume":"81","author":"Leuzzi","year":"2013","journal-title":"Infect. Immun."},{"issue":"18","key":"10.1016\/j.molimm.2014.09.005_bib1005","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1015","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/IAI.35.3.1147-1150.1982","article-title":"Biological activities of toxins A and B of Clostridium difficile","volume":"35","author":"Lyerly","year":"1982","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/IAI.47.2.349-352.1985","article-title":"Effects of Clostridium difficile toxins given intragastrically to animals","volume":"47","author":"Lyerly","year":"1985","journal-title":"Infect. Immun."},{"issue":"7242","key":"10.1016\/j.molimm.2014.09.005_bib1025","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nature07822","article-title":"Toxin B is essential for virulence of Clostridium difficile","volume":"458","author":"Lyras","year":"2009","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.molimm.2014.09.005_bib1030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.molmed.2012.09.005","article-title":"Immune responses to Clostridium difficile infection","volume":"18","author":"Madan","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/gut.38.3.337","article-title":"Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment","volume":"38","author":"Mahida","year":"1996","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.molimm.2014.09.005_bib1040","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/IAI.66.11.5462-5469.1998","article-title":"Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis","volume":"66","author":"Mahida","year":"1998","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib1045","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1053\/gast.1996.v111.pm8898641","article-title":"Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum","volume":"111","author":"Mantyh","year":"1996","journal-title":"Gastroenterology"},{"issue":"37","key":"10.1016\/j.molimm.2014.09.005_bib1050","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1039\/c1cc13614c","article-title":"Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit","volume":"47","author":"Martin","year":"2011","journal-title":"Chem. Commun. (Camb)."},{"issue":"12","key":"10.1016\/j.molimm.2014.09.005_bib1055","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1074\/jbc.M607614200","article-title":"Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels","volume":"282","author":"Matarrese","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"Pt 5","key":"10.1016\/j.molimm.2014.09.005_bib1060","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1099\/mic.0.045997-0","article-title":"The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile","volume":"157","author":"McBride","year":"2011","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib1065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anaerobe.2009.09.002","article-title":"Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections","volume":"15","author":"McFarland","year":"2009","journal-title":"Anaerobe"},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1469-0691.2011.03571.x","article-title":"The economic burden of Clostridium difficile","volume":"18","author":"McGlone","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib1070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.disamonth.2009.04.010","article-title":"Clostridium difficile","volume":"55","author":"McFee","year":"2009","journal-title":"Dis. Mon."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib1075","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1592\/phco.27.7.1029","article-title":"Clostridium difficile: recent epidemiologic findings and advances in therapy","volume":"27","author":"McMaster-Baxter","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.molimm.2014.09.005_bib1080","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/AAC.44.9.2254-2258.2000","article-title":"In vitro and in vivo activities of nitazoxanide against Clostridium difficile","volume":"44","author":"McVay","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib1085","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1128\/IAI.00195-07","article-title":"Clostridium difficile toxins A and B directly stimulate human mast cells","volume":"75","author":"Meyer","year":"2007","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1463-1318.2006.01013.x","article-title":"Risk factors for severity and relapse of pseudomembranous colitis in an elderly population","volume":"9","author":"Moshkowitz","year":"2007","journal-title":"Colorectal Dis."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib1095","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1053\/j.gastro.2005.01.053","article-title":"Clostridium difficile toxin B activates the EGF receptor and the ERK\/MAP kinase pathway in human colonocytes","volume":"128","author":"Na","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib1100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/0962935031000096917","article-title":"Human intestinal epithelial and smooth muscle cells are potent producers of IL-6","volume":"12","author":"Ng","year":"2003","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1053\/j.gastro.2010.04.005","article-title":"Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome","volume":"139","author":"Ng","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.femsle.2005.04.005","article-title":"Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins","volume":"246","author":"O\u2019Brien","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1115","doi-asserted-by":"crossref","first-page":"e17623","DOI":"10.1371\/journal.pone.0017623","article-title":"The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A","volume":"6","author":"Olling","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib1120","doi-asserted-by":"crossref","first-page":"e10673","DOI":"10.1371\/journal.pone.0010673","article-title":"Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis","volume":"5","author":"Papatheodorou","year":"2010","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.molimm.2014.09.005_bib1125","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2007.02.055","article-title":"Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile","volume":"25","author":"Pechine","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib1130","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1128\/IAI.65.4.1402-1407.1997","article-title":"Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196","volume":"65","author":"Perelle","year":"1997","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1139\/w97-145","article-title":"Protease activity of Clostridium difficile strains","volume":"44","author":"Poilane","year":"1998","journal-title":"Can. J. Microbiol."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1140","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1073\/pnas.91.3.947","article-title":"CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin","volume":"91","author":"Pothoulakis","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molimm.2014.09.005_bib1145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1749-6632.2000.tb05263.x","article-title":"Effects of Clostridium difficile toxins on epithelial cell barrier","volume":"915","author":"Pothoulakis","year":"2000","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.molimm.2014.09.005_bib1150","first-page":"28","article-title":"Toward a structural understanding of Clostridium difficile toxins A and B","volume":"2","author":"Pruitt","year":"2012","journal-title":"Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib1155","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/IAI.65.7.2740-2746.1997","article-title":"Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes","volume":"65","author":"Rocha","year":"1997","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.molimm.2014.09.005_bib1160","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1128\/IAI.66.10.4910-4916.1998","article-title":"Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta","volume":"66","author":"Rocha","year":"1998","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib1170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14787210.2014.866515","article-title":"Clostridium difficile infection: molecular pathogenesis and novel therapeutics","volume":"12","author":"Rineh","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"Pt 1","key":"10.1016\/j.molimm.2014.09.005_bib1175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1099\/mic.0.27474-0","article-title":"Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells","volume":"151","author":"Rupnik","year":"2005","journal-title":"Microbiology"},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib1180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib1185","doi-asserted-by":"crossref","first-page":"e1002076","DOI":"10.1371\/journal.ppat.1002076","article-title":"A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins","volume":"7","author":"Ryan","year":"2011","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejpb.2011.05.011","article-title":"Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile","volume":"79","author":"Sandolo","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0016-5085(03)00902-8","article-title":"Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine","volume":"125","author":"Savidge","year":"2003","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.molimm.2014.09.005_bib1200","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nm.2405","article-title":"Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins","volume":"17","author":"Savidge","year":"2011","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.molimm.2014.09.005_bib1205","doi-asserted-by":"crossref","first-page":"e1000626","DOI":"10.1371\/journal.ppat.1000626","article-title":"Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria","volume":"5","author":"Schwan","year":"2009","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1099\/00222615-31-3-169","article-title":"Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model","volume":"31","author":"Seddon","year":"1990","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1215","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1473-3099(13)70052-5","article-title":"Faecal transplantation for recurrent C. difficile diarrhoea","volume":"13","author":"Senior","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000332946","article-title":"Clostridium difficile toxins: mediators of inflammation","volume":"4","author":"Shen","year":"2012","journal-title":"J. Innate Immun."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib1225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.diagmicrobio.2007.10.022","article-title":"Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea","volume":"60","author":"Shin","year":"2008","journal-title":"Diagn Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib1230","first-page":"19","article-title":"The host immune response to Clostridium difficile infection","volume":"1","author":"Solomon","year":"2013","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"19","key":"10.1016\/j.molimm.2014.09.005_bib1235","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1128\/JB.00610-10","article-title":"Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid","volume":"192","author":"Sorg","year":"2010","journal-title":"J. Bacteriol."},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib1240","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/14787210.2013.814767","article-title":"Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections","volume":"11","author":"Soriano","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1245","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","article-title":"Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea","volume":"128","author":"Sougioultzis","year":"2005","journal-title":"Gastroenterology"},{"issue":"Pt 3","key":"10.1016\/j.molimm.2014.09.005_bib1250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1099\/jmm.0.46931-0","article-title":"Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains","volume":"56","author":"Stare","year":"2007","journal-title":"J. Med. Microbiol."},{"issue":"6","key":"10.1016\/j.molimm.2014.09.005_bib1255","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.micpath.2009.03.002","article-title":"Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages","volume":"46","author":"Sun","year":"2009","journal-title":"Microb. Pathog."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib1260","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/toxins2071848","article-title":"The enterotoxicity of Clostridium difficile toxins","volume":"2","author":"Sun","year":"2010","journal-title":"Toxins (Basel)."},{"issue":"7","key":"10.1016\/j.molimm.2014.09.005_bib1265","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/IAI.01336-10","article-title":"Mouse relapse model of Clostridium difficile infection","volume":"70","author":"Sun","year":"2011","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib1270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-010-0155-7","article-title":"Current status of nonantibiotic and adjunct therapies for Clostridium difficile infection","volume":"13","author":"Suwantarat","year":"2011","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"12","key":"10.1016\/j.molimm.2014.09.005_bib1275","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1128\/IAI.69.12.7937-7940.2001","article-title":"Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization","volume":"69","author":"Tasteyre","year":"2001","journal-title":"Infect. Immun."},{"issue":"27\u201328","key":"10.1016\/j.molimm.2014.09.005_bib0085","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.vaccine.2008.04.042","article-title":"Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A","volume":"26","author":"Taylor","year":"2008","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.molimm.2014.09.005_bib0090","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.vaccine.2012.04.045","article-title":"A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models","volume":"30","author":"Tian","year":"2012","journal-title":"Vaccine"},{"issue":"956","key":"10.1016\/j.molimm.2014.09.005_bib1280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/pgmj.2004.028480","article-title":"Pathogenesis and treatment of Clostridium difficile infection","volume":"81","author":"Tonna","year":"2005","journal-title":"Postgrad. Med. J."},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0016-5085(87)91014-6","article-title":"Differential effects of Clostridium difficile toxins A and B on rabbit ileum","volume":"93","author":"Triadafilopoulos","year":"1987","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/gmic.19399","article-title":"Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response","volume":"3","author":"Vedantam","year":"2012","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.molimm.2014.09.005_bib0360","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0378-1119(90)90348-U","article-title":"Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases","volume":"96","author":"von Eichel-Streiber","year":"1990","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.molimm.2014.09.005_bib1290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","article-title":"Clostridium difficile toxins: mechanism of action and role in disease","volume":"18","author":"Voth","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.molimm.2014.09.005_bib1295","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/IAI.69.4.2144-2153.2001","article-title":"Characterization of a cell surface protein of Clostridium difficile with adhesive properties","volume":"69","author":"Waligora","year":"2001","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib1300","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.00215-12","article-title":"A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection","volume":"80","author":"Wang","year":"2012","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.molimm.2014.09.005_bib0440","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI7545","article-title":"p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis: IL-8 production, and enteritis","volume":"105","author":"Warny","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.molimm.2014.09.005_bib1305","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0016-5085(98)70315-4","article-title":"Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice","volume":"114","author":"Wershil","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molimm.2014.09.005_bib1310","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome","author":"Xu","year":"2011","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.molimm.2014.09.005_bib1315","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM198204293061701","article-title":"Infectious gastroenteritis in bone-marrow-transplant recipients","volume":"306","author":"Yolken","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib0575","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lfs.2012.11.017","article-title":"Clostridium difficile flagellin stimulates toll-like receptor 5, and toxin B promotes flagellin-induced chemokine production via TLR5","volume":"92","author":"Yoshino","year":"2013","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.molimm.2014.09.005_bib1320","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea: stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin. Infect. Dis."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014002417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014002417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T17:09:12Z","timestamp":1689527352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589014002417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":157,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0161589014002417"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2014.09.005","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}